Back

IABP Shock II Trial and its impact on clinical practice: Has it changed our management for cardiogenic shock complicating acute myocardial infarction?

15 October 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Cardiac shock Cardiac shock ACVC Premium Access Acute Cardiovascular Care 2016

About the speaker

Photo
Doctor Jorge Nuche

Hospital Universitario 12 de Octubre, Madrid (Spain)

6 More presentations in this session

Presentation thumbnail
Anticoagulation in patients with intra-aortic balloon pump. Is it always necessary?
Doctor R. San Antonio (Barcelona, ES)
Abstract
Presentation thumbnail
In-hospital mortality and long term outcome of ST-segment elevation acute myocardial infarction complicated with cardiogenic shock in the era of primary angioplasty
Doctor F. Rueda Sobella (Barcelona, ES)
Abstract Slides
Presentation thumbnail
The impact of admission blood glucose level on clinical picture and prognosis in cardiogenic shock
Doctor A. Kataja (Helsinki, FI)
Abstract
Presentation thumbnail
Admission glycaemia in patients with acute coronary syndrome complicated by cardiogenic shock: differences by myocardial infarction classification
Doctor R. Ilhao Moreira (Lisbon, PT)
Abstract
Presentation thumbnail
Right ventricular dysfunction is an independent predictor of cardiogenic shock development following acute myocardial infarction
Doctor C. Quina-Rodrigues (Braga, PT)

Access the full session

Session thumbnail
Poster Session 3 - Cardiac shock

The Event

Event poster

Acute Cardiovascular Care 2016

15 October - 17 October 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources